Format
Sort by
Items per page

Send to

Choose Destination

Links from PubChem Compound

Items: 1 to 20 of 1139

1.

Fibrates for primary prevention of cardiovascular disease events.

Jakob T, Nordmann AJ, Schandelmaier S, Ferreira-González I, Briel M.

Cochrane Database Syst Rev. 2016 Nov 16;11:CD009753. Review.

PMID:
27849333
2.

Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease.

Younis A, Younis A, Tzur B, Peled Y, Shlomo N, Goldenberg I, Fisman EZ, Tenenbaum A, Klempfner R.

Cardiovasc Diabetol. 2016 Oct 28;15(1):149.

3.

Efficacy of bezafibrate on fibroblasts of glutaric acidemia type II patients evaluated using an in vitro probe acylcarnitine assay.

Yamada K, Kobayashi H, Bo R, Purevsuren J, Mushimoto Y, Takahashi T, Hasegawa Y, Taketani T, Fukuda S, Yamaguchi S.

Brain Dev. 2017 Jan;39(1):48-57. doi: 10.1016/j.braindev.2016.08.004. Epub 2016 Aug 30.

PMID:
27591119
4.

Identification of microRNA profiles associated with refractory primary biliary cirrhosis.

Sakamoto T, Morishita A, Nomura T, Tani J, Miyoshi H, Yoneyama H, Iwama H, Himoto T, Masaki T.

Mol Med Rep. 2016 Oct;14(4):3350-6. doi: 10.3892/mmr.2016.5606. Epub 2016 Aug 9.

PMID:
27511723
5.

In vitro evidence in rainbow trout supporting glucosensing mediated by sweet taste receptor, LXR, and mitochondrial activity in Brockmann bodies, and sweet taste receptor in liver.

Otero-Rodiño C, Velasco C, Álvarez-Otero R, López-Patiño MA, Míguez JM, Soengas JL.

Comp Biochem Physiol B Biochem Mol Biol. 2016 Oct;200:6-16. doi: 10.1016/j.cbpb.2016.04.010. Epub 2016 Apr 29.

PMID:
27139261
6.

Accumulation of pharmaceuticals in groundwater under arid climate conditions - Results from unsaturated column experiments.

Zemann M, Majewsky M, Wolf L.

Chemosphere. 2016 Jul;154:463-71. doi: 10.1016/j.chemosphere.2016.03.136. Epub 2016 Apr 13.

PMID:
27085060
7.

Evaluation of the simultaneous removal of recalcitrant drugs (bezafibrate, gemfibrozil, indomethacin and sulfamethoxazole) and biodegradable organic matter from synthetic wastewater by electro-oxidation coupled with a biological system.

Rodríguez-Nava O, Ramírez-Saad H, Loera O, González I.

Environ Technol. 2016 Dec;37(23):2964-74. doi: 10.1080/09593330.2016.1172669. Epub 2016 Apr 28.

PMID:
27043245
8.

Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease: Twenty-Two-Year Follow-Up of the Bezafibrate Infarction Prevention Study and Registry.

Klempfner R, Erez A, Sagit BZ, Goldenberg I, Fisman E, Kopel E, Shlomo N, Israel A, Tenenbaum A.

Circ Cardiovasc Qual Outcomes. 2016 Mar;9(2):100-8. doi: 10.1161/CIRCOUTCOMES.115.002104. Epub 2016 Mar 8. Erratum in: Circ Cardiovasc Qual Outcomes. 2016 Sep;9(5):613.

9.

Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial.

Arbel Y, Klempfner R, Erez A, Goldenberg I, Benzekry S, Shlomo N, Fisman EZ, Tenenbaum A; BIP Study Group..

Cardiovasc Diabetol. 2016 Jan 22;15:11. doi: 10.1186/s12933-016-0332-6.

10.

Cerium doped red mud catalytic ozonation for bezafibrate degradation in wastewater: Efficiency, intermediates, and toxicity.

Xu B, Qi F, Sun D, Chen Z, Robert D.

Chemosphere. 2016 Mar;146:22-31. doi: 10.1016/j.chemosphere.2015.12.016. Epub 2015 Dec 17.

PMID:
26706928
11.

Fibrates inhibit the apoptosis of Batten disease lymphoblast cells via autophagy recovery and regulation of mitochondrial membrane potential.

Hong M, Song KD, Lee HK, Yi S, Lee YS, Heo TH, Jun HS, Kim SJ.

In Vitro Cell Dev Biol Anim. 2016 Mar;52(3):349-55. doi: 10.1007/s11626-015-9979-7. Epub 2015 Dec 10.

PMID:
26659390
12.

Novel Therapies on Primary Biliary Cirrhosis.

Czul F, Levy C.

Clin Liver Dis. 2016 Feb;20(1):113-30. doi: 10.1016/j.cld.2015.08.006. Review.

PMID:
26593294
13.

Bovine (Bos taurus) Bone Marrow Mesenchymal Cell Differentiation to Adipogenic and Myogenic Lineages.

Ramírez-Espinosa JJ, González-Dávalos L, Shimada A, Piña E, Varela-Echavarria A, Mora O.

Cells Tissues Organs. 2016;201(1):51-64. doi: 10.1159/000440878. Epub 2015 Nov 13.

PMID:
26565958
14.

Fibrates for secondary prevention of cardiovascular disease and stroke.

Wang D, Liu B, Tao W, Hao Z, Liu M.

Cochrane Database Syst Rev. 2015 Oct 25;(10):CD009580. doi: 10.1002/14651858.CD009580.pub2. Review.

PMID:
26497361
15.

Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis.

Yin Q, Li J, Xia Y, Zhang R, Wang J, Lu W, Zhou Y, Zheng Y, Abudumijiti H, Chen R, Chen K, Li S, Liu T, Wang F, Lu J, Zhou Y, Guo C.

Drug Des Devel Ther. 2015 Sep 30;9:5407-19. doi: 10.2147/DDDT.S92041. eCollection 2015. Review. Erratum in: Drug Des Devel Ther. 2015;9:5947.

16.

Bezafibrate-mizoribine interaction: Involvement of organic anion transporters OAT1 and OAT3 in rats.

Feng Y, Wang C, Liu Q, Meng Q, Huo X, Liu Z, Sun P, Yang X, Sun H, Qin J, Liu K.

Eur J Pharm Sci. 2016 Jan 1;81:119-28. doi: 10.1016/j.ejps.2015.10.008. Epub 2015 Oct 22.

PMID:
26474691
17.

Short-term selective alleviation of glucotoxicity and lipotoxicity ameliorates the suppressed expression of key β-cell factors under diabetic conditions.

Shimo N, Matsuoka TA, Miyatsuka T, Takebe S, Tochino Y, Takahara M, Kaneto H, Shimomura I.

Biochem Biophys Res Commun. 2015 Nov 27;467(4):948-54. doi: 10.1016/j.bbrc.2015.10.038. Epub 2015 Oct 20.

PMID:
26471305
18.

Ketogenic response to cotreatment with bezafibrate and medium chain triacylglycerols in healthy humans.

Courchesne-Loyer A, St-Pierre V, Hennebelle M, Castellano CA, Fortier M, Tessier D, Cunnane SC.

Nutrition. 2015 Oct;31(10):1255-9. doi: 10.1016/j.nut.2015.05.015. Epub 2015 Jun 6.

PMID:
26333891
19.

Prospective study of bezafibrate for the treatment of primary sclerosing cholangitis.

Mizuno S, Hirano K, Isayama H, Watanabe T, Yamamoto N, Nakai Y, Sasahira N, Tada M, Omata M, Koike K.

J Hepatobiliary Pancreat Sci. 2015 Oct;22(10):766-70. doi: 10.1002/jhbp.281. Epub 2015 Aug 21.

PMID:
26173026
20.

Response to Licinio et al.

Sato K, Hosonuma K, Kusano M, Yamada M.

Am J Gastroenterol. 2015 Jul;110(7):1086-7. doi: 10.1038/ajg.2015.166. No abstract available.

PMID:
26148264

Supplemental Content

Support Center